tert-Butyl (2-(2-aminoethoxy)ethoxy)carbamate

Catalog No. :
ACFLIQ135
CAS No. :
1844894-82-1
Molecular Formula :
C9H20N2O4
Molecular Weight :
220.27

IUPAC Name:tert-butyl (2-(2-aminoethoxy)ethoxy)carbamate

tert-Butyl (2-(2-aminoethoxy)ethoxy)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg98%$112.00Login to see priceIn stockInquiry
50mg98%$202.00Login to see priceIn stockInquiry
100mg98%$337.00Login to see priceIn stockInquiry
250mg98%$595.00Login to see priceIn stockInquiry
1g98%$1686.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (2-(2-aminoethoxy)ethoxy)carbamate
IUPAC Nametert-butyl (2-(2-aminoethoxy)ethoxy)carbamate
MDL No.MFCD31561111
Molecular FormulaC9H20N2O4
Molecular Weight220.27
SMILESO=C(NOCCOCCN)OC(C)(C)C
InChI KeyTTYYGLYRGAJOLR-UHFFFAOYSA-N
Synonymt-Boc-Aminooxy-PEG1-amine;Boc-Aminooxy-PEG1-C2-NH2;Carbamic acid, N-[2-(2-aminoethoxy)ethoxy]-, 1,1-dimethylethyl ester;t-Boc-Aminooxy-PEG1-amine boc-;tert-Butyl [2-(2-aminoethoxy)ethoxy]carbamate
CAS No.1844894-82-1

Safety Data

Pictogram
FlammableHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H225-H315-H319-H335
Precautionary Statement(s)
P210-P240-P241-P242-P243-P261-P264-P271-P280-P302+P352-P303+P361+P353-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P370+P378-P403+P233-P403+P235-P405-P501

Synthetic Route by SureRoute

1. ACFLIQ135 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFLIQ135 route product structure diagram
    ACFLIQ1351844894-82-1 In Stock
Inquiry

2. ACFLIQ135 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFLIQ135 route product structure diagram
    ACFLIQ1351844894-82-1 In Stock
Inquiry

Comments (0)